Generation and characterization of induced pluripotent stem cell (iPSC) lines from patients affected with Tay-Sachs and Sandhoff disease
Open Access
- 3 March 2026
- journal article
- Published by Elsevier in Stem Cell Research
- Vol. 92, 103949
Abstract
No abstract availableKeywords
Funding Information
- National Center for Advancing Translational Sciences
- National Institutes of Health
- U.S. Department of Health and Human Services
This publication has 5 references indexed in Scilit:
- Therapeutic Strategies For Tay-Sachs DiseaseFrontiers in Pharmacology, 2022
- A versatile polypharmacology platform promotes cytoprotection and viability of human pluripotent and differentiated cellsNature Methods, 2021
- A cost-effective and efficient reprogramming platform for large-scale production of integration-free human induced pluripotent stem cells in chemically defined cultureScientific Reports, 2015
- Clarifying lysosomal storage diseasesTrends in Neurosciences, 2011
- GeneReviews®1993